Foghorn Therapeutics

FHTX

NASDAQHealth Care

Income Statement

Total Revenue$22.6M

Gross Profit$22.6M

Operating Income$-102.68M

EBITDA$-77.82M

EBIT$-86.62M

Pre-tax Income$-74.28M

Net Income$-86.62M

Cash Equivalent$84.54M

Total Debt$40.02M

Book Value$-46.41M

Book Value Per Share-0.95

Return on Equity (ROE)-108880.00%

Return on Assets (ROA)-30.50%

Return on Invested Capital (ROI)-108880.00%

Net Profit Margin-383.24%

Current Ratio3.73

Quick Ratio3.64

Long-Term Debt / Equity0.00